- Home
- MBI vs CRDF Comparison
MBI vs CRDF Comparison
Compare MBI & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- CRDF
- Stock Information
- Founded
- MBI 1973
- CRDF 1999
- Country
- MBI United States
- CRDF United States
- Employees
- MBI N/A
- CRDF N/A
- Industry
- MBI Property-Casualty Insurers
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBI Finance
- CRDF Health Care
- Exchange
- MBI Nasdaq
- CRDF Nasdaq
- Market Cap
- MBI 278.8M
- CRDF 288.7M
- IPO Year
- MBI 1987
- CRDF N/A
- Fundamental
- Price
- MBI $5.01
- CRDF $3.29
- Analyst Decision
- MBI Buy
- CRDF Strong Buy
- Analyst Count
- MBI 2
- CRDF 4
- Target Price
- MBI $6.75
- CRDF $12.00
- AVG Volume (30 Days)
- MBI 349.9K
- CRDF 1.1M
- Earning Date
- MBI 05-08-2025
- CRDF 05-01-2025
- Dividend Yield
- MBI N/A
- CRDF N/A
- EPS Growth
- MBI N/A
- CRDF N/A
- EPS
- MBI N/A
- CRDF N/A
- Revenue
- MBI $27,000,000.00
- CRDF $683,000.00
- Revenue This Year
- MBI N/A
- CRDF N/A
- Revenue Next Year
- MBI N/A
- CRDF N/A
- P/E Ratio
- MBI N/A
- CRDF N/A
- Revenue Growth
- MBI 285.71
- CRDF 39.96
- 52 Week Low
- MBI $3.22
- CRDF $2.01
- 52 Week High
- MBI $7.46
- CRDF $6.38
- Technical
- Relative Strength Index (RSI)
- MBI 34.01
- CRDF 36.56
- Support Level
- MBI $5.01
- CRDF $3.65
- Resistance Level
- MBI $5.58
- CRDF $3.88
- Average True Range (ATR)
- MBI 0.26
- CRDF 0.26
- MACD
- MBI 0.01
- CRDF -0.06
- Stochastic Oscillator
- MBI 10.53
- CRDF 2.59
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").